<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04868994</url>
  </required_header>
  <id_info>
    <org_study_id>RC31/20/0217</org_study_id>
    <nct_id>NCT04868994</nct_id>
  </id_info>
  <brief_title>Magnetic Imaging for Diagnostic of Amyotrophic Lateral Sclerosis</brief_title>
  <acronym>MIDALS</acronym>
  <official_title>Contribution of Whole Body Muscle MRI for Early Diagnosis of Amyotrophic Lateral Sclerosis.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Toulouse</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Toulouse</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Nearly 60% of Amyotrophic Lateral Sclerosis (ALS) patients have a low level of diagnostic&#xD;
      certainty (possible, probable) at the time of diagnosis. In the absence of biomarkers, this&#xD;
      diagnosis is based, among other things, on the demonstration of the diffusion of signs of&#xD;
      denervation by electroneuromyography (ENMG). The objective of this study is to improve the&#xD;
      earliness and the level of diagnostic certainty by better demonstrating the diffusion of the&#xD;
      denervation process by whole body muscular MRI.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of this study is to show that the combination of ENMG and whole body muscle MRI&#xD;
      (WB-MRI) can increase the diagnosis of definite ALS at the onset of the disease For 50&#xD;
      consecutive patients with suspected ALS, the present study will prospectively perform needle&#xD;
      electromyography (EMG) and muscle analyses on whole body MRI. The diagnostic category will be&#xD;
      determined by revised El Escorial criteria and Awaji criteria. On whole body MRI acquisition,&#xD;
      for 83 muscles, will be explored fatty infiltration and atrophy on fat images (chronic&#xD;
      denervation) and muscle edema on water images (acute denervation). EMG studies will be&#xD;
      performed in at least 10 muscles (tongue, biceps brachii, first dorsalis interosseous, T10&#xD;
      paraspinalis, vastus lateralis, and tibialis anterior). Diagnostic classification according&#xD;
      EMG and/ or MRI abnormalities in bulbar and the 3 spinal regions will be compared&#xD;
      independently.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">June 1, 2021</start_date>
  <completion_date type="Anticipated">December 2022</completion_date>
  <primary_completion_date type="Anticipated">April 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Diagnostic certainty 1.ENMG according to El Escorial revised criteria using ENMG alone, MRI alone and ENMG+MRI to define denervation diffusion</measure>
    <time_frame>1 month</time_frame>
    <description>number of patients classified as possible, probable or certain according to El Escorial criteria using ENMG alone, IMR alone and ENMR+MRI</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Define precise topographic and characteristic of muscle involvement in ALS by MRI</measure>
    <time_frame>1 month</time_frame>
    <description>number of patients with concordance between ENMG and MRI for the detection of denervation</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Amyotrophic Lateral Sclerosis With Dementia</condition>
  <arm_group>
    <arm_group_label>ENMG and muscle analyses on whole body muscles MRI.</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Diffusion of active and chronic muscle denervation will be assessed on ENMG and whole body muscle MRI. The diagnostic category will be determined by revised El Escorial criteria and Awaji criteria</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Whole Body MRI and ENMG</intervention_name>
    <description>Whole body muscle MRI lasting 30 to 45 min without injection of contrast medium an ENMG</description>
    <arm_group_label>ENMG and muscle analyses on whole body muscles MRI.</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Consent form signed by the patient&#xD;
&#xD;
          -  Patients suspected ALS defined according Awaji Shima criteria (possible, probable,&#xD;
             defined)&#xD;
&#xD;
          -  Clinical assessment of upper motor neuron involvement&#xD;
&#xD;
          -  Electrophysiologic assessment of lower motor neuron involvement&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  inability to give informed consent&#xD;
&#xD;
          -  a contraindication to MRI&#xD;
&#xD;
          -  respiratory failure impairing ability to lie flat in the scanner.&#xD;
&#xD;
          -  Patient placed under judicial protection or under another protective regime,&#xD;
&#xD;
          -  Females who are pregnant&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>99 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Pascal CINTAS, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Toulouse</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Pascal CINTAS, MD PHD</last_name>
    <phone>05 61 77 94 40</phone>
    <email>cintas.p@chu-toulouse.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Anne Cecile Coville</last_name>
    <phone>(05345) 58700</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Pascal CINTAS</name>
      <address>
        <city>Toulouse</city>
        <zip>31000</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Pascal CINTAS, MD PHD</last_name>
      <phone>0561779440</phone>
      <email>cintas.p@chu-toulouse.fr</email>
    </contact>
    <contact_backup>
      <last_name>Anne Cecile Coville</last_name>
      <phone>0534558700</phone>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>June 2021</verification_date>
  <study_first_submitted>March 26, 2021</study_first_submitted>
  <study_first_submitted_qc>April 27, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">May 3, 2021</study_first_posted>
  <last_update_submitted>June 2, 2021</last_update_submitted>
  <last_update_submitted_qc>June 2, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">June 7, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Amyotrophic</keyword>
  <keyword>Sclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Motor Neuron Disease</mesh_term>
    <mesh_term>Amyotrophic Lateral Sclerosis</mesh_term>
    <mesh_term>Sclerosis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

